Today: 10 April 2026

Social Security COLA 2026: The Raise EVERYONE Is Talking About — And Why It Might Fall Short

Social Security COLA 2026: The Raise EVERYONE Is Talking About — And Why It Might Fall Short

The Social Security Administration will announce the 2026 cost-of-living adjustment on Oct. 24, delayed by the recent government shutdown. Early estimates put the increase at 2.7%, or about $54 more per month for the average retiree. Rising Medicare Part B premiums and costs for essentials are expected to offset much of the gain. Senior groups argue the current COLA formula understates retirees’ expenses.
24 October 2025
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft shares closed near $520, up 25% year-to-date, with a market cap approaching $3.8 trillion. Azure cloud revenue jumped 39% last quarter, outpacing AWS and Google Cloud. Wall Street remains bullish, with 32 of 34 analysts rating MSFT a “Buy” and a 12-month price target near $620–630. Microsoft reports Q1 FY2026 results on Oct. 29, with analysts expecting continued double-digit growth.
Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

Reviva Pharma Rockets 28% on Schizophrenia Trial Win – Analysts Eye 1000% Upside

RVPH shares closed at $0.57 on Oct 24 after a volatile month, swinging between $0.26 and $0.84. The stock surged 28% on Oct 23 following recent Phase 3 trial results for brilaroxazine and news of an upcoming FDA meeting. Reviva raised about $19 million this year to fund its CNS pipeline. Analyst targets average $6.25, implying a potential 1,000% upside.
AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

AMD Stock Skyrockets on AI Mega-Deals – Is $300 Next?

AMD shares jumped 34% on Oct. 6 after announcing major AI GPU deals with OpenAI and Oracle, adding $80 billion in market value. The stock is up about 80–95% year-to-date, reaching all-time highs near $238 before settling at $235 by Oct. 23. Analysts raised price targets to as high as $310. Q2 2025 revenue rose 32% to $7.69 billion, with full-year sales guidance near $33 billion.
Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science Stock Skyrockets on Strategic Gene-Therapy Alliance – Is a $25 Price Target Next?

Genenta Science shares surged over 300% in early trading Oct. 24 after announcing an expanded partnership with Anemocyte to develop off-the-shelf lentiviral vector plasmid DNA for cell therapies. The company’s lead candidate Temferon showed a 29% two-year survival rate in glioblastoma patients, more than double standard care. Net loss narrowed to €3.83M in H1 2025. Analyst targets average $22.73, far above current prices.
Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Plug Power (PLUG) Stock Skyrockets 170% on Hydrogen Hype – Can It Last?

Plug Power shares traded near $2.88 on Oct. 23, up about 170% since early September. The company secured a 1 GW electrolyzer order from Fortescue and delivered its first 10 MW unit to Galp’s Portugal project. Plug raised $370 million through warrant exercises on Oct. 8. Founder/CEO Andy Marsh will move to Executive Chair in 2026, with José Luis Crespo set to become CEO.
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ stock surged to a record near $82 in mid-October 2025, then dropped about 25% to close at $59.40 on Oct. 23 after heavy trading and news of possible U.S. government investment. A $2 billion equity deal and a quantum computing milestone fueled volatility. Wall Street targets range from $32 to $100, with consensus in the mid-$50s. IonQ will report Q3 results on Nov. 5.
CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike (CRWD) Stock Soars on AI Cybersecurity Boom — Record Highs

CrowdStrike closed at $521.98 on Oct. 23, just below its all-time high, after rising nearly 40% year-to-date. Q2 FY2026 revenue reached $1.17 billion, up 21% year-over-year, with EPS of $0.93, both beating estimates. The company acquired Onum for $290 million and launched new AI security features. About 28 of 48 analysts rate CRWD a Buy, with average price targets near $496.
Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Palantir-Lumen AI Deal Sparks Stock Rally – CEO Warns of “Arms Race”

Lumen will invest over $200 million in Palantir under a multi-year partnership pairing Palantir’s AI platform with Lumen’s network infrastructure, both firms confirmed Oct. 23. Lumen shares jumped about 10% on the news, while Palantir stock has surged over 2,600% since early 2023. The deal marks a shift for both companies toward enterprise AI services. Lumen reports Q3 earnings Oct. 30; Palantir reports Nov. 3.
Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies Stock Blasts Off After $14B Mega-Merger – Will RKT Keep Soaring?

Rocket Companies closed a $14.2 billion acquisition of Mr. Cooper Group on Oct. 1, the largest mortgage merger to date. RKT stock trades near $17, up about 80% year-to-date but below its early October high of $22.56. Shares have rallied 50% since the merger was announced in March, with short interest at 57%. Q3 earnings are due Oct. 30, with analysts expecting EPS of $0.04, down 50% year-over-year.
American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines Lifts Profit Outlook, AAL Stock Rockets – Travel Boom or Turbulence Ahead?

American Airlines raised its 2025 profit outlook to $0.65–$0.95 EPS, up from a prior forecast of up to a $0.20 loss. Shares jumped 6% to $12.77 on Thursday. Third-quarter revenue hit a record $13.7 billion, while adjusted earnings showed a smaller-than-expected loss at -$0.17 per share. Premium cabin sales and cost controls offset flat overall revenue.
24 October 2025
Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx Biosciences Stock Soars on Breakthrough Cancer Trial News

Inhibrx’s ozekibart cut risk of progression or death by 52% in Phase 2 chondrosarcoma trial, doubling median progression-free survival to 5.52 months versus placebo. Shares of INBX jumped about 70% intraday and closed at $28.36 on Oct. 23, then surged another 75–80% after hours. Management plans a BLA filing in Q2 2026. Ozekibart also showed high response rates in colorectal and Ewing sarcoma cohorts.
Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Denison Mines (DNN) Rides Uranium Boom as Wheeler River Advances – What’s Next?

Denison Mines shares more than doubled in 2025, reaching multi-year highs as uranium prices hit $80–$83 per pound. The company’s Wheeler River project secured key provincial permits and awaits a federal license by December. Denison restarted uranium production for the first time in 15 years and raised $345 million for growth. All five brokerages covering Denison rate the stock a “Buy” or “Outperform.”
Broadcom (AVGO) Stock Skyrockets on $10B OpenAI AI Chip Deal – Are $450 Price Targets Next?

Broadcom (AVGO) Stock Skyrockets on $10B OpenAI AI Chip Deal – Are $450 Price Targets Next?

Broadcom shares closed at $344 on Oct. 23, about double their price a year ago. The stock jumped nearly 10% on Oct. 13 after Broadcom and OpenAI announced a deal to co-design $10 billion in AI chips. Q3 revenue rose 22% to $15.95 billion, and management raised Q4 guidance above consensus. Analysts remain bullish, with most targets in the mid-$300s and some as high as $460.
Incredible Rally: Bitfarms (BITF) Stock Jumps 148% YTD Amid Crypto Boom & AI Pivot

Bitfarms (BITF) Stock Whipsaws as Bitcoin Hits Record High, $500M AI Pivot Fuels Rally – What’s Next?

Bitfarms shares traded near $4.10 on Oct. 24 after plunging 40% from a 52-week high of $6.20 reached Oct. 14, tracking sharp swings in Bitcoin prices. The company raised $588 million this month to fund a new HPC/AI campus in Pennsylvania and announced CFO Jeff Lucas will retire Oct. 27, replaced by Jonathan Mir. Bitfarms remains unprofitable, posting a $29 million Q2 loss on $78 million revenue.
Opendoor’s Wild 2025 Ride: Meme-Stock Surge, Crypto Pivot & Housing Hopes – What’s Next for OPEN?

Opendoor’s 1600% Meme-Stock Rally Meets Reality – New CEO, Crypto Hype & Housing Woes Collide

Opendoor shares surged from under $1 to over $10 in 2025, driven by retail hype, before settling near $7 in late October. The company named Kaz Nejatian as CEO and signaled plans for up to 85% layoffs. Q2 revenue rose 5% to $1.6 billion, but Q3 sales are forecast to fall by half. Most analysts rate the stock a “Sell,” with price targets far below current levels.

Stock Market Today

  • Fortis (TSX:FTS) Valuation Analysis Amid Strong Five-Year Growth
    April 10, 2026, 3:50 PM EDT. Fortis has delivered a 75.3% return over five years, sparking debate on its current valuation. The stock closed at C$79.30, marking steady gains but underperforming peers with 29.9% year-to-date return. A Discounted Cash Flow (DCF) model, which estimates the company's intrinsic value by forecasting future cash flows and discounting them to present value, values Fortis at approximately C$163.46 per share. This implies the stock is 51.5% undervalued versus its current price, suggesting potential upside. However, the company's recent free cash flow showed a loss of C$1,339.6 million, expected to turn positive by 2030. Fortis scores a moderate 3 out of 6 on Simply Wall St's valuation checklist, reflecting mixed signals for investors. Analysts note that while Fortis provides stability and income as a regulated utility, its price reflects cautious risk and growth expectations.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 3:51 PM EDT Is Scotts Miracle-Gro (SMG) Undervalued After Five-Year Price Drop? April 10, 2026, 3:51 PM EDT. Scotts Miracle-Gro shares have fallen 68% over five years but gained 29.6% in the last year. The company, a key player in lawn and garden products, currently trades around $62.54. A Discounted Cash Flow (DCF) analysis estimates the intrinsic value at $83.64, suggesting the stock is approximately 25% undervalued. SMG's price-to-earnings ratio of 22.2 is below the Chemicals industry average, indicating a potentially attractive valuation. Simply Wall St scores SMG
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Go toTop